 Anti-ischemic effects atenolol versus nifedipine patients coronary artery disease ambulatory silent ischemia anti-ischemic effects atenolol nifedipine randomized double-blind crossover manner patients stable exertional angina transient silent ischemia ambulatory electrocardiographic ECG monitoring atenolol nifedipine effective average number duration transient ischemic events therapy atenolol reduction mean number duration silent ischemic events Analyses silent ischemic activity morning hours therapy atenolol significant reduction average duration patient average duration silent ischemia event AM noon adverse experiences therapy atenolol results atenolol nifedipine effective silent ischemic events treatment atenolol efficacy morning surge silent myocardial ischemia